Aussie Court Rules For Generic Versions Of Sanofi-Aventis Taxotere
This article was originally published in PharmAsia News
Executive Summary
An Australian federal court opened the market to generic versions of Sanofi-Aventis' cancer drug, Taxotere (docetaxel)